Q2 2024 EPS Estimates for Tango Therapeutics, Inc. (NASDAQ:T

Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) – Stock analysts at HC Wainwright lowered their Q2 2024 earnings per share estimates for Tango Therapeutics in a research note issued to investors on Tuesday, May 28th. HC Wainwright analyst R. Burns now forecasts that the company will post earnings of ($0.36) per share for the quarter, […]

Related Keywords

Piper Sandler , Boxer Capital , Tango Therapeutics Company Profile , Tango Therapeutics Inc , Nasdaq , Mva Investors Llc , Deerfield Management Companylp Series , Cantor Fitzgerald , Artal Group , Securities Exchange Commission , Barclays , Tango Therapeutics , Free Report , Tango Therapeutic , Get Free Report , Mva Investors , Exchange Commission , Tango Therapeutics Daily ,